WIERENGA WENDELL bought CYTK
July 15, 2026 · Form 4 insider transaction
WIERENGA WENDELL bought 75 shares of Cytokinetics, Incorporated at $82.62 per share, a transaction worth $6.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75
Price
$82.62
Total value
$6.2K
InsiderWIERENGA WENDELL
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 16, 2026
Shares owned after35,563
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant.